Article Details
Retrieved on: 2021-08-16 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
mRNA-3705 is Moderna's second rare disease program to enter clinical studies. mRNA-3705 granted Orphan Drug and Rare Pediatric Disease ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here